“…The majority of these studies showed that methotrexate (MTX) and leflunomide were able to induce apoptosis in vitro in a variety 1 c-kit tyrosine kinase is a mast/stem cell growth factor receptor also known as CD117 [131] 2 ZAP-70, ζ-chain-associated protein-70 and a member of the tyrosine kinase family that is normally expressed by T-cells and natural killer cells [132] 3 SIRT1 is silent mating type information regulation 2 homolog (sirtuin-1) and a deacetylating enzyme [133] 4 PAR-2, Protease-activated receptor-2 and a subfamily member related to G-protein coupled receptors that may be activated by cleavage through their extracellular domain [134] 5 NF-AT5, Nuclear factor of activated T-cells 5 belonging to the NFAT family of transcription factors [135] 6 Human umbilical vascular endothelial cells 7 Mcl-1, Induced myeloid leukemia cell differentiation protein [136] 8 Epigallocatechin-3-gallate 9 MDC, myeloid-derived cells; PDC, plasmacytoid-derived cells 10 Apaf-1, Apoptotic protease activating factor-1 11 An inhibitor of geranylgeranyl transferase [137] 12 An inhibitor of RhoA kinase [138] 1 REL1096 is the p65 (Rel A) subunit of NF-κB 2 GADD45β is the growth arrest and DNA-damage-inducible45β protein [148] 3 Putative consensus sites for the binding of miR-124a and miR-146a to the 3'-untranslated regions of cyclin-dependent kinase-2 (CDK-2) and MCP-1, respectively 4 Putative consensus site for the binding of miR-146a to the 3' untranslated region of Fas-associated factor-1 of cells pertinent to RA pathology as well as cells involved in generalized inflammation, including, T-cells, neutrophils, mast cells and macrophages. By contrast, although NSAIDS were proposed as potential apoptosis inducers [166], the NSAID, celecoxib, failed to induce apoptosis in RAFLS in vitro [171].…”